基于淋巴结影像学特征的联合预测模型评价局部进展期直肠癌患者行新辅助放化疗后淋巴结转移的应用价值

Application value of a joint prediction model based on lymph node imaging features in evalua-ting lymph node metastasis of locally advanced rectal cancer patients after neoadjuvant che-moradiotherapy

  • 摘要:
    探讨基于淋巴结影像学特征的联合预测模型评价局部进展期直肠癌(LARC)患者行新辅助放化疗(nCRT)后淋巴结转移的应用价值。
    采用回顾性队列研究方法。收集2010年7月至2015年6月北京大学肿瘤医院收治的215例LARC患者的临床病理资料;男131例,女84例;年龄为(56.7±10.1)岁。215例患者采用随机种子数按2∶1比例分为训练集143例和测试集72例。训练集用于构建预测模型,测试集用于验证预测模型效能。观察指标:(1)LARC患者行nCRT后淋巴结转移情况。(2)影像学特征筛选与模型构建及评价。正态分布的计量资料组间比较采用独立样本t检验。偏态分布的计量资料组间比较采用Mann⁃Whitney U检验。计数资料组间比较采用χ2检验。单因素分析和多因素分析采用Logistic回归模型。预测模型的效能评价采用受试者工作特征(ROC)曲线分析,并计算曲线下面积(AUC)、准确度、灵敏度、特异度,采用校准曲线和决策曲线评价预测模型的一致性和临床应用价值。
    (1)LARC患者行nCRT后淋巴结转移情况。215例LARC患者行nCRT后,经术后病理学检查结果显示:淋巴结转移阴性162例,淋巴结转移阳性53例;两者年龄、最大淋巴结短径比较,差异均有统计学意义(t=2.178,Z=-5.305,P<0.05)。(2)影像学特征筛选与模型构建及评价。215例LARC患者行nCRT后,共提取41个影像学特征,包括9个灰度一阶特征、24个灰度共生矩阵特征和8个几何形状特征。162例淋巴结转移阴性和53例淋巴结转移阳性患者淋巴结得分(LNscore)分别为0.18(0.10,0.33)分和0.39(0.23,0.54)分,两者比较,差异有统计学意义(Z=-5.487,P<0.05)。多因素分析结果显示:最大淋巴结短径和LNscore是LARC患者行nCRT后淋巴结转移的独立影响因素(比值比=1.277、25.514,95%可信区间为1.010~1.614、2.003~324.964,P<0.05)。纳入最大淋巴结短径和LNscore构建Logistic回归联合预测模型。ROC曲线结果显示:联合预测模型在训练集中的AUC为0.779(95%可信区间为0.702~0.844)、准确度为72.7%、灵敏度为71.4%、特异度为73.2%;测试集上述指标分别为0.805(95%可信区间为0.694~0.889)、80.6%、66.7%、85.2%。联合预测模型训练集和验证集的校准曲线与标准曲线均贴合较好,校准度较高。决策曲线显示:列线图模型净收益较高。
    最大淋巴结短径和LNscore是LARC患者行nCRT后淋巴结转移的独立影响因素。基于上述指标构建的联合预测模型可用于LARC患者行nCRT后淋巴结转移的预测。

     

    Abstract:
    Objective To investigate the application value of a joint prediction model based on lymph node imaging features in evaluating lymph node metastasis of locally advanced rectal cancer (LARC) patients after neoadjuvant chemoradiotherapy (nCRT).
    Methods The retrospective cohort study was conducted. The clinicopathological data of 215 LARC patients who were admitted to Peking University Cancer Hospital & Institute from July 2010 to June 2015 were collected. There were 131 males and 84 females, aged (56.7±10.1)years. All 215 patients were randomly divided into a training set of 143 cases and a testing set of 72 cases using a 2∶1 ratio of random seed numbers. The training set was used to construct the prediction model, and the testing set was used to validate the performance of prediction model. Observation indicators: (1) lymph node metastasis in LARC patients after nCRT; (2) imaging feature selection and model construction and evaluation. Com-parison of measurement data with normal distribution between groups was conducted using the independent sample t test. Comparison of measurement data with skewed distribution between groups was conducted using the Mann-Whitney U test. Comparison of count data between groups was conducted using the chi‑square test. Univariate and multivariate analyses were conducted using the Logistic regression model. Performance evaluation of prediction model was conducted using the receiver operating characteristic (ROC) curve. The area under the curve (AUC), accuracy, sensitivity, and specificity were calculated. Calibration curves and decision curves were used to evaluate the consistency and clinical application value of the prediction model.
    Results (1) Lymph node metastasis in LARC patients after nCRT. Of the 215 LARC patients after nCRT, results of postoperative pathological examination showed that there were 162 cases with negative lymph node metastasis and 53 cases with positive lymph node metastasis, showing significant differences in age and maximum short‑axis diameter of lymph node between them (t=2.178, Z=-5.305, P<0.05). (2) Imaging feature selection and model construction and evaluation. Forty‑one imaging features were extracted from the 215 LARC patients after nCRT, including 9 gray-level first‑order features, 24 gray‑level co‑occurrence matrix features and 8 shape features. The score of lymph node (LNscore) in 162 cases with negative lymph node metastasis and 53 cases with positive lymph node metastasis were 0.18(0.10,0.33) and 0.39(0.23,0.54), respectively, showing a significant difference between them (Z=-5.487, P<0.05). Results of multivariate analysis showed that maximum short‑axis diameter of lymph node and LNscore were independent factors influencing lymph node metastasis of LARC patients after nCRT (odds ratio=1.277, 25.514, 95% confidence interval as 1.010-1.614, 2.003-324.964, P<0.05). A Logistic regression joint prediction model was constructed by incorporating the maximum short-axis diameter of lymph node and LNscore. The ROC curves results showed that the AUC, accuracy, sensitivity, and specificity of the joint prediction model in the training set were 0.779 (95% confidence interval as 0.702-0.844), 72.7%, 71.4%, and 73.2%, respectively. The above indicators in the testing set were 0.805 (95% confidence interval as 0.694-0.889), 80.6%, 66.7%, and 85.2%, respectively. Calibration curves in both training set and test set showed good agreement with the ideal curve, indicating high calibration. Decision curves demonstrated the model′s clinical utility with a high net benefit.
    Conclusion The maximum short‑axis diameter of lymph node and LNscore are independent factors influencing lymph node metastasis of LARC patients after nCRT. The joint prediction model constructed based on the above indicators can be used to predict lymph node metastasis in LARC patients after nCRT.

     

/

返回文章
返回